"Boston Clinical Trials and Medical Research, Inc. is an independent, multi specialty, women-owned and operated clinical research center located in Boston."

During the past decade, Boston Clinical Trials conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 57 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 41 clinical trials were completed. i.e. 93.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston Clinical Trials" #1 sponsor was "Eli Lilly and Company" with 18 trials, followed by "Pfizer" with 13 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 7 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 6 trials sponsored and "Allergan" with 6 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston Clinical Trials" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator and "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Boston Clinical Trials" are "Migraine" (18 trials), "Depressive Disorder, Major" (8 trials), "Binge Eating Disorder" (6 trials), "Major Depressive Disorder" (6 trials) and "Migraine, With or Without Aura" (6 trials). Many other conditions were trialed in "Boston Clinical Trials" in a lesser frequency.

Most popular intervention types in "Boston Clinical Trials" are "Drug" (108 trials), "Other" (3 trials), "Device" (2 trials), "Genetic" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (68 trials), "Rimegepant" (8 trials), "Galcanezumab" (6 trials), "Rapastinel" (5 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Boston Clinical Trials" are 99 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Boston Clinical Trials". undefined are not yet recruiting, 19 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 76 completed trials in Boston Clinical Trials, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Boston Clinical Trials, 1 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 3 trials that are defined as “Not Applicable".